Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Cocrystal Pharma, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q2 2025
- Shares held
- 665.0K
- −21.5K (−3.1%) vs. Q2 2025
- Total value
- $831.3K
- −$191.7K (−18.7%) vs. Q2 2025
- New holders
- 4
- 3 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.01M |
| Q4 2023 | 17 | $1.17M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.95M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 16 | $20 | 0.00% | +16 | New |
| SBI Securities Co., Ltd. | 34 | $43 | 0.00% | +1+3.0% | Added |
| NVWM, LLC | 84 | $105 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 237 | $297 | 0.00% | 00.0% | Unchanged |
| Clean Yield Group | 418 | $523 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 571 | $714 | 0.00% | −21,344−97.4% | Reduced |
| Northwestern Mutual Wealth Management Co | 817 | $1.02K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,053 | $1.32K | 0.00% | +1,053 | New |
| Wells Fargo & Company | 1,812 | $2.27K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,298 | $4.12K | 0.00% | −365−10.0% | Reduced |
| Morgan Stanley | 5,863 | $7.33K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9,092 | $11.4K | 0.00% | −9−0.1% | Reduced |
| Northern Trust Corp | 11,921 | $14.9K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 12,611 | $15.8K | 0.00% | −2,617−17.2% | Reduced |
| State Street Corp | 20,543 | $25.7K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 21,044 | $26.3K | 0.00% | +21,044 | New |
| Neuberger Berman Group LLC | 31,886 | $39.9K | 0.00% | +31,886 | New |
| BlackRock, Inc. | 73,746 | $92.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 73,929 | $92.4K | 0.00% | +829+1.1% | Added |
| Renaissance Technologies LLC | 127,928 | $159.9K | 0.00% | +2,900+2.3% | Added |
| Vanguard Group Inc | 268,080 | $335.1K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,619−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,092−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −215−100.0% | Sold out |